This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a …

Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more

~Estimated

~$10 – $8,750

Chugai PharmaceuticalNCT06371417

Prevalence and Clinical Severity of Autoimmune Blistering Diseases

Pemphigus and bullous pemphigoid (BP) are severe autoimmune blistering diseases (AIBD) that pose a critical need for new therapeutic approaches. Clinical trial…

Pemphigus VulgarisPemphigus FoliaceusBullous Pemphigoid

~Estimated

~$10 – $750

University of PennsylvaniaNCT02753777